What is TeraBAT?
TeraBAT operates at the intersection of advanced analytical chemistry and portable diagnostic hardware. By leveraging its unique terawave technology, the company provides high-precision detection and quantification of volatile organic compounds (VOCs). This capability is essential for industries requiring rigorous quality control and safety standards, such as food safety, agriculture, and healthcare. By facilitating real-time, simultaneous detection of multiple contaminants, TeraBAT effectively disrupts traditional, slower laboratory-based testing models. Their platform not only enhances operational transparency but also ensures strict adherence to regulatory frameworks like FDA standards, positioning the company as a vital infrastructure provider for modern industrial safety and compliance.
How much funding has TeraBAT raised?
TeraBAT has raised a total of $1.1M across 1 funding round:
Private Equity
$1.1M
Private Equity (2016): $1.1M, investors not publicly disclosed
Key Investors in TeraBAT
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for TeraBAT?
With this major strategic investment, TeraBAT is poised to transition from its current development phase into a broader market expansion strategy. The company is expected to prioritize the commercialization of its portable diagnostic units, targeting high-growth sectors where real-time VOC monitoring is a critical pain point. Future initiatives will likely focus on refining the terawave platform to increase sensitivity and throughput, thereby broadening its utility in complex manufacturing and public safety environments. As the firm scales, the focus will shift toward establishing long-term partnerships with enterprise-level clients, further cementing its role as a leader in the rapid diagnostic technology landscape.
See full TeraBAT company page
